Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry.

Monika GawalkoPiotr LodzińskiMonika BudnikAgata TymińskaAnna WancerzKrzysztof OzierańskiAgnieszka Kapłon-CieślickaMarcin GrabowskiGrzegorz OpolskiRadosław LenarczykZbigniew KalarusGregory Y H LipPaweł Balsam

Published in: International journal of clinical practice (2020)

VD was prevalent in almost two-fifths of AF patients. The incidence of MAE was higher in patients with VD on VKA (vs NOAC) and on triple therapy (vs dual therapy, OAC alone) within one-year follow-up.

Keyphrases

end stage renal disease
atrial fibrillation
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
risk factors
stem cells
mesenchymal stem cells
patient reported